We are a leading player in the probiotic space

AB-BIOTICS is a leading player in the probiotic space that makes advanced probiotic science a reality. Our mission? To propel the biotics sector forward and make these important ingredients mainstream, foster innovation and inspire the creation of unique solutions that will truly impact the lives of consumers globally.

Today, you can find our products in more than 80 markets worldwide.

We’ve been advancing the probiotic landscape since 2004

Founded as a spinoff of Autonomous University of Barcelona (UAB)– launched by Miquel Àngel Bonachera and Sergi Audivert (current Executive Directors)
2004
First trip to South America (Perú) to gather microbiota samples of non-industrialized, healthy populations
2005
R&D developed New Pipeline Group (NPG)
2010
Probiotic clinical trials initiated
2011
First probiotics launched to the market
2013
KANEKA Corporation partners with AB-BIOTICS to sell its probiotics in North America and Japan
2018
KANEKA Corporation acquires AB-BIOTICS – both companies collaborate to advance microbiome research and development
2019
Launch of the direct-to-consumer brand, Floradapt®, in several markets
2021
Introduction of probiotic products for use in functional foods and drugs
2022

Global by nature

AB-BIOTICS is a KANEKA Company

KANEKA Corporation is an international chemical manufacturing company established in 1949. Headquartered in Osaka, Japan, it is a $5+ billion producer of chemical goods – including resins, pharmaceutical intermediaries, food supplements, synthetic fibers and fine chemicals – powered by 9,600+ employees worldwide.

Tower Osaka, where there are the KANEKA offices

Miquel Àngel Bonachera and Sergi Audivert from AB-BIOTICS

Powered by science, delivered by experts

The dynamic AB-BIOTICS team brings together almost 100 experienced and forward-thinking individuals led by Co-founders, Miquel Àngel Bonachera and Sergi Audivert.

Get to know the team